Eckert & Ziegler SE (FRA:EUZ)
59.45
+0.35 (0.59%)
Last updated: May 12, 2025
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 68.19M EUR in the quarter ending March 31, 2025, with 0.85% growth. This brings the company's revenue in the last twelve months to 296.43M, up 15.89% year-over-year. In the year 2024, Eckert & Ziegler SE had annual revenue of 295.85M with 20.22% growth.
Revenue (ttm)
296.43M
Revenue Growth
+15.89%
P/S Ratio
4.11
Revenue / Employee
273.20K
Employees
1,085
Market Cap
1.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 76.54B |
Deutsche Telekom AG | 118.43B |
Allianz SE | 107.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 35.76B |
Merck KGaA | 21.16B |
Eckert & Ziegler SE News
- 17 hours ago - Eckert & Ziegler Q1 2025 Growth Confirms 2025 Forecast - Wallstreet:Online
- 17 hours ago - EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast - Wallstreet:Online
- 11 days ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 19 days ago - EQS-News: Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE - Wallstreet:Online
- 19 days ago - EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm - Wallstreet:Online
- 4 weeks ago - EQS-DD: Eckert & Ziegler SE: Dr. Harald Hasselmann, Allocation of 18,048 shares as part of executive board remuneration (own shares of the issuer). This is a share-based remuneration with an ... - Wallstreet:Online
- 4 weeks ago - EQS-News: Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 - Wallstreet:Online
- 4 weeks ago - EQS-News: Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig - Wallstreet:Online